Latest: Watch here for details of new products and services.
- About Us
- Pharmalicensing - Open Innovation for the life sciences
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Due Diligence
- Comparison
- Due Diligence
- Overview
- Top Applications
- Online Panel Discussions
- Request Consultation
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire
- Jobs
- Forums
- Contact Pharmalicensing
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
A liquid system which enables rapid transmigration of therapeutic doses of up to large molecules More
Coupling drug substances with hydroxyethyl starch (HES) derivatives to improve pharmacokinetics and pharmacodynamics. More
This ORS effervescent tablet has been developed according to the latest guidelines of the WHO. We are looking for partners in Europe and in other areas to commercialize the ORS effervescent tablets More
Comfortable, better distribution, "shower-head' Vaginal Applicator More
Novel Dual Chamber Dispenser with polycarbonate and stainless steel components for accurate Rx dosing. More
Phytohealth Corporation: PH3 (PHN031, PHN033) - For osteoporosis and diabetic vascular complications
Patented technology regarding new and safe mechanism with the active substance PH3 for the indications of osteoporosis and diabetic vascular complications. More
Cliovelle - a low dose Estradiol / Progestin combination product for treatment of menopausal disorders. More
Currently, LTS has two matrix formulation under development varying in their manufacturing process More
LPCN 1002 is a branded product for female hormonal disorders currently in Phase I studies specifically targeting Endometrial hyperplasia and secondary amenorrhea. More
Oral candidate created to replace androgen, with the potential of being the first oral bio replacement product in the U.S. More
Your selection
Browse By
- Industry sector
- Generics
- Nutrition
- OTC/Non-Prescription
- Pediatric
- Personal Care
- Prescription
- Therapeutic target
- Amenorrahea
- Androgen deficiency
- Endocrine system
- Estrogen replacement
- Growth disorders
- Hormonal disorder (other)
- Hormone replacement therapy
- Hurler's syndrome
- Hypogonadism
- Hypothalamic
- Menopause
- Pancreatic exocrine insufficiency
- Sex hormone (other)
- Testosterone replacement
- Thyroid disorders
- Turner's syndrome
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us